Cargando…
Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance
Enzymes are critically important in the transportation, metabolism, and clearance of most therapeutic drugs used in clinical practice today. Many of these enzymes have significant genetic polymorphisms that affect the enzyme's rate kinetics. Regarding drug metabolism, specific polymorphisms to...
Autor principal: | Wu, Alan HB |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170273/ https://www.ncbi.nlm.nih.gov/pubmed/21906384 http://dx.doi.org/10.1186/1559-0275-8-12 |
Ejemplares similares
-
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
por: Ahmed, Shabbir, et al.
Publicado: (2016) -
Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy
por: Li, Jing, et al.
Publicado: (2011) -
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine
por: Arbitrio, Mariamena, et al.
Publicado: (2016) -
Pharmacogenomics in Personalized Medicine and Drug Metabolism
por: Chang, Wei-Chiao
Publicado: (2014) -
Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)